Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology (STELLA)
Dementia, Alzheimer Disease, Caregiver Burnout
About this trial
This is an interventional supportive care trial for Dementia
Eligibility Criteria
Care Recipient Inclusion:
- Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), moderate to late stages
- Exhibits 2 or more behaviors listed on Revised Memory and Behavioral Problems (RMBP) that are bothersome to the Care Partner and occur 3 or more times/week at study enrollment
- Family member of Care Partner (this can be a relative, spouse or close kin that is considered family)
Care Recipient Exclusion:
- Dementia not related to ADRD
- Unable to leave Care Partner during Care Partner training
- Early stage dementia, as defined by a Montreal Cognitive Assessment (MoCA) of about 15/30 or higher.
Care Partner Inclusion:
- Adult caring for family member with ADRD
- Lives with care recipient OR spends at least 4 hours/week with care recipient
- Age of 18 years or older
- Speak English
- Own a computer/device with a reliable internet connection and compatible operating system
Care Partner Exclusion:
- Unable to find activity for care recipient during training which would allow Care Partner to work privately, one-on-one during training
- Completed similar telehealth intervention within the last year
- Hearing and vision problems severe enough to prevent participation
- Unwilling or unable to adequately follow study instructions and participate in study procedures
Inclusion for Care Recipient and Care Partner:
Participate in Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology (ORCASTRAIT) (IRB#20236) Participant in the ORCASTRAIT study (IRB # 20236)
Sites / Locations
- Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center
Arms of the Study
Arm 1
Other
Intervention
Care Partners and Persons with Dementia. Up to 40 Care Partners and their 40 care-recipients with ADRD will participate in this study. The primary focus of this study is on Care Partners, however, we will gather subjective and objective data on participants with Alzheimer's Disease and Related Dementias (ADRD) to assess the effect of the intervention on Care Partner affective responses to caregiving and quality of life for both. STELLA participants will be recruited from the existing cohort of patients, and their Care Partners, who are enrolled in the Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology) ORCASTRAIT Life Laboratory (OSLL).